SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-057027
Filing Date
2014-09-22
Accepted
2014-09-22 09:23:51
Documents
2
Group Members
CITADEL ADVISORS HOLDINGS II LPCITADEL GP LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G v389691_sc13g.htm SC 13G 121051
2 EXHIBIT 99.1 v389691_ex99-1.htm EX-99.1 6923
  Complete submission text file 0001144204-14-057027.txt   129772
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 141113169
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CITADEL LLC 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address C/O CITADEL LLC 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G